| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Havencrest Healthcare Partners, L.P. is a 10% Owner at Oncology Institute, Inc.. Recent SEC Form 4 filings include 0 buys and 26 sells.
Estimated insider holdings value: $31.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 29, 2024 | TOI Oncology Institute, Inc. | 10% Owner | Sell | 8,637 | $2.12 | $18,310.44 | -100% | -49.8% | -63.6% | |
| Jan 26, 2024 | TOI Oncology Institute, Inc. | 10% Owner | Sell | 43,776 | $2.21 | $96,835.30 | -45.8% | -44.6% | -64.3% | |
| Jan 23, 2024 | TOI Oncology Institute, Inc. | 10% Owner | Sell | 27,587 | $2.12 | $58,550.92 | -13.4% | -46.4% | -66.6% | |
| Nov 11, 2022 | TOI Oncology Institute, Inc. | 10% Owner | Sell | 365,321 | $2.33 | $851,197.93 | -2.7% | -31.8% | +13.8% | |
| Nov 10, 2022 | TOI Oncology Institute, Inc. | 10% Owner | Sell | 168,281 | $3.07 | $517,297.38 | -0.4% | -48.3% | -16.0% | |
| Nov 7, 2022 | TOI Oncology Institute, Inc. | 10% Owner | Sell | 114,867 | $3.45 | $395,935.76 | -0.3% | -54.0% | -47.0% | |
| Nov 2, 2022 | TOI Oncology Institute, Inc. | 10% Owner | Sell | 150,627 | $4.26 | $640,948.67 | -0.4% | -61.5% | -50.3% | |
| Oct 28, 2022 | TOI Oncology Institute, Inc. | 10% Owner | Sell | 139,591 | $5.02 | $701,170.44 | -0.3% | -69.8% | -60.9% | |
| Oct 25, 2022 | TOI Oncology Institute, Inc. | 10% Owner | Sell | 79,800 | $5.02 | $400,652.00 | -0.2% | -71.8% | -67.3% | |
| Oct 20, 2022 | TOI Oncology Institute, Inc. | 10% Owner | Sell | 41,700 | $4.71 | $196,346.00 | - | -65.6% | -67.7% |